Related Experiment Video
Updated: Aug 14, 2026

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Development of posterior subcapsular cataracts in asthmatic children
Insights
Asthmatic children on long-term steroid therapy face a higher risk of developing posterior subcapsular cataracts (PSCC). Markedly delayed bone age alongside steroid use exceeding two years are key indicators for PSCC risk in these children.
Area of Science:
- Ophthalmology
- Pediatrics
- Endocrinology
Background:
- Posterior subcapsular cataracts (PSCC) are a known complication of systemic corticosteroid therapy.
- Identifying children with asthma at risk for PSCC is crucial for proactive management.
Purpose of the Study:
- To evaluate factors associated with systemic steroid administration that may influence PSCC development in asthmatic children.
- To identify specific risk factors for PSCC in pediatric asthma patients undergoing steroid treatment.
Main Methods:
- Retrospective evaluation of 40 asthmatic children receiving systemic steroids.
- Assessment of steroid duration, dose, frequency of bursts, bone age retardation, and mode of administration.
- Correlation of these factors with the presence or absence of PSCC.
Main Results:
- Seven out of 40 (17.5%) asthmatic children developed PSCC.
- All children with PSCC had received steroids for at least two years and exhibited markedly delayed bone age.
- The combination of prolonged steroid use (≥2 years) and markedly delayed bone age was strongly associated with PSCC development.
Conclusions:
- Asthmatic children on systemic steroids for two years or longer with markedly delayed bone age are at significantly increased risk for PSCC.
- Duration of steroid therapy and bone age retardation are critical predictors for PSCC in this pediatric population.
Abstract:
Posterior subcapsular cataracts (PSCC) are known complications of systemic steroid therapy. Previous studies have not clearly identified the asthmatic children at risk for the development of PSCC. The possible factors associated with systemic steroid administration that may influence the development of PSCC in asthmatic children were evaluated: (1) duration of administered steroids, (2) dose, (3) number of steroid "bursts" in the preceding year, (4) degree of retardation of bone age, and (5) mode of administration (daily or alternate day) of steroids. Of the 40 asthmatic children requiring steroids, seven (17.5%) had PSCC. All of the children with PSCC had been receiving steroids on a daily or alternate-day basis for at least 2 years and all had markedly delayed bone age. Only one child with the concurrent occurrence of these two factors did not develop PSCC. None of the other risk factors considered could distinguish the group of patients with PSCC. It is concluded that asthmatic children receiving steroids for 2 years or longer and having markedly delayed bone age are at a greater risk for the development of PSCC.
Related Concept Videos
Glaucoma: Overview
Photoreceptors and Visual Pathways

